Transgelin-2 expression in breast cancer and its relationships with clinicopathological features and patient outcome.

Ruifang HaoYang LiuQian DuLeichao LiuSiying ChenHaisheng YouYa-Lin Dong

Published in: Breast cancer (Tokyo, Japan) (2019)

Transgelin-2 was expressed significantly higher in breast cancer cells and correlated with some clinicopathological factors. High transgelin-2 expression might predict poor prognosis for ER-negative patients.

Keyphrases

poor prognosis
long non coding rna
breast cancer cells
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
case report
patient reported outcomes
estrogen receptor
endoplasmic reticulum